The Journal of Urology
Volume 181, Issue 3 , Pages 1028-1034, March 2009

Genetic Deficiency of Complement Isoforms C4A or C4B Predicts Improved Survival of Metastatic Renal Cell Carcinoma

Department of Experimental Therapeutics and Division of Quantitative Sciences (WW, MMJ), University of Texas M. D. Anderson Cancer Center, Houston, Texas

Received 25 July 2008 published online 16 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received M. D. Anderson Cancer Center institutional review board approval.

 Supported by National Institutes of Health CA111369 (JAE).

 The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

PII: S0022-5347(08)03040-1

doi:10.1016/j.juro.2008.11.013

The Journal of Urology
Volume 181, Issue 3 , Pages 1028-1034, March 2009

Article Tools

* Image Usage & Resolution